Koyfin Home > Directory > Health Care > Kindred Biosciences > Levered Free Cash Flow (FCF)

Kindred Biosciences Levered Free Cash Flow (FCF) Chart (KIN)

Kindred Biosciences annual/quarterly Levered Free Cash Flow (FCF) from 2013 to 2020.
  • Kindred Biosciences Levered Free Cash Flow (FCF) for the quarter ending June 06, 2020 was $-10m a 51.81% decrease of -5m year over year
  • Kindred Biosciences Levered Free Cash Flow (FCF) for the last 12 months ending June 06, 2020 was $-33m a -36.02% increase of 12m year over year
  • Kindred Biosciences Annual Levered Free Cash Flow (FCF) for 2019 was $-45m a 21.38% decrease of -10m from 2018
  • Kindred Biosciences Annual Levered Free Cash Flow (FCF) for 2018 was $-35m a 50.44% decrease of -18m from 2017
  • Kindred Biosciences Annual Levered Free Cash Flow (FCF) for 2017 was $-17m a 37.07% decrease of -6m from 2016
Other Cash Flow Metrics:
  • Kindred Biosciences Cash Flow from Operations for the quarter ending December 12, 2018 was $-13m a 12.86% decrease of -2m year over year
  • Kindred Biosciences Total Revenue for the quarter ending September 09, 2018 was $1m
View Chart On Koyfin

Quarterly KIN Levered Free Cash Flow (FCF) Data

06/2020$-10m
03/2020$-9m
12/2019$-9m
09/2019$-5m
06/2019$-15m
03/2019$-16m
12/2018$-9m
09/2018$-13m
06/2018$-5m
03/2018$-8m

Annual KIN Levered Free Cash Flow (FCF) Data

2019$-45m
2018$-35m
2017$-17m
2016$-11m
2015$-13m
2014$-13m
2013$0m